Docoh
Loading...

MTCR Metacrine

News

From Benzinga Pro
Stocks That Hit 52-Week Lows On Wednesday
19 Jan 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
During Wednesday's morning trading, 400 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Friday
7 Jan 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
Before 10 am on Friday, 110 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Thursday
6 Jan 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Thursday, 615 stocks hit new 52-week lows.
51 Biggest Movers From Yesterday
28 Dec 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Microbot Medical Inc. (NASDAQ: MBOT) shares climbed 65.1% to close at $8.95 on Monday after the company announced a strategic collaboration with Stryker Corporation to develop the LIBERTY robotic system for neurovascular applications.
5 Value Stocks In The Healthcare Sector
27 Dec 21
News
Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
63 Biggest Movers From Friday
20 Dec 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Spruce Biosciences, Inc. (NASDAQ: SPRB) jumped 102.8% to close at $5.03 on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15 price target.
Overview Of Value Stocks In The Healthcare Sector
29 Nov 21
News
What are Value Stocks?
Metacrine Posts Data From MET409 Combination Trial In Diabetes, NASH Patients
2 Nov 21
Biotech, News, Penny Stocks, Health Care, General
How The Future Looks For Last Week's Biggest Losers: Vinco Ventures, Atea Pharmaceuticals And More
25 Oct 21
News, Penny Stocks, Small Cap, Movers, Trading Ideas
Last week, the five biggest stock market losers declined between about 75% and 37%. Below is a look at each stock and what they may have in the cards going forward.
55 Biggest Movers From Friday
25 Oct 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers
Mid-Afternoon Market Update: Nasdaq Down 70 Points; Ocular Therapeutix Shares Drop
22 Oct 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Toward the end of trading Friday, the Dow traded up 0.23% to 35,685.44 while the NASDAQ fell 0.46% to 15,145.51. The S&P also fell, dropping 0.01% to 4,549.46.
Mid-Day Market Update: Snap Drops After Q3 Results; Creatd Shares Jump
22 Oct 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Midway through trading Friday, the Dow traded up 0.25% to 35,690.68 while the NASDAQ fell 0.46% to 15,145.78. The S&P also rose, gaining 0.02% to 4,550.53.
35 Stocks Moving In Friday's Mid-Day Session
22 Oct 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers
Canaccord Genuity Downgrades Metacrine to Hold, Lowers Price Target to $1
22 Oct 21
News, Downgrades, Price Target, Analyst Ratings
Canaccord Genuity analyst Edward Nash downgrades Metacrine (NASDAQ:MTCR) from Buy to Hold and lowers the price target from $19 to $1.
Benzinga's Top Ratings Upgrades, Downgrades For October 22, 2021
22 Oct 21
Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings
Upgrades
Mid-Morning Market Update: Markets Mixed; American Express Earnings Beat Views
22 Oct 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Following the market opening Friday, the Dow traded up 0.39% to 35,741.08 while the NASDAQ fell 0.38% to 15,157.83. The S&P also rose, gaining 0.06% to 4,552.71.
26 Stocks Moving in Friday's Pre-Market Session
22 Oct 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers
HC Wainwright & Co. Downgrades Metacrine to Neutral
22 Oct 21
News, Downgrades, Analyst Ratings
HC Wainwright & Co. analyst Ed Arce downgrades Metacrine (NASDAQ:MTCR) from Buy to Neutral.